BY ALBERT RONNING-ANDERSSON
-
Lundbeck’s bid for Longboard had rivals
As early as December 2023, Lundbeck contacted Longboard’s CEO to explore partnership opportunities, according to reports filed with the US SEC
-
Climate change brings major French vaccine producer north
With a brand new Nordic headquarters in Copenhagen’s Metropolis Corridor Sq., French Stallergenes Greer plans to interrupt ALK’s maintain on the Danish market.
-
Genmab partners with US oncology firm Revitope
The Danish biotech firm is paying USD 9 million present moment to Boston-based Revitope Oncology in a collaboration that might set off turning point settlements to Revitope of as m…
-
Sanofi makes “strategic investment” in biotech developing second-generation obesity drug
The biotech firm Resalis Therapies is creating a prospective second-generation obestity therapy based upon study from Aalborg College, to name a few.
-
Stallergenes Greer to expand with new subsidiary in Copenhagen
French injection programmer Stallergenes Greer, rival to ALK out there for allergic reaction therapies, is increasing with a subsidiary in Copenhagen committed to the Nordic area.
-
Leo Pharma hires head of IR ahead of possible IPO
Christian Sørup Ryom signs up with Leo Pharma from Danske Financial Institution, where he has actually covered Coloplast, Ambu, Demant and GN as Head of Equity Study.
-
Novo Holdings co-founds cancer company with biotech profile as CEO
Along with teachers from Basel, Novo Holdings has actually introduced a brand-new firm called Akylox Rehabs with skilled biotech business owner Martin Bonde as president.
-
Lundbeck’s billion-dollar acquisition will cost layoffs
Specifically in the monitoring of Longboard Pharmaceuticals, there will certainly be discharges as an outcome of Lundbeck’s procurement on Monday for USD 2.5 bn, claims Lundb…
-
Lundbeck to acquire US company for USD 2.5bn
The Danish pharmaceutical firm buys Longboard Prescribed drugs for USD 2.5bn.
-
Lundbeck director sees AI as a future competitive parameter
To remain in advance of the contour, Lundbeck depends on both inner and exterior AI systems, yet human treatment will certainly still be required for a long time.
